Betamox Plus 400

Quick links

Choose a section

Quick links to important sections

Advertisements

Betamox Plus 400

Selected form

Advertisements

Overview of Betamox Plus 400

Quick Facts

Property Description
Active ingredient Amoxicillin, Clavulanic Acid
Form Tablet or Powder for oral suspension
Pharmacological class Potentiated Penicillin / Antibacterial Agent
Common purpose Systemic elimination of susceptible bacterial pathogens
Origin Synthetic/Semi-synthetic combination

What Type of Antibiotic is Betamox Plus 400?

Betamox Plus 400 is identified by the official non-proprietary name, Co-amoxiclav (Amoxicillin/Clavulanic Acid), and is a fixed-dose combination product used to manage bacterial infections. It is classified as a broad-spectrum antibacterial agent belonging to the potentiated penicillin class. This strategic formulation is recognized globally for its high efficacy against numerous infections.

The medicine is a synthetic compound that is clinically crucial for treating complicated infections that may not respond to Amoxicillin when used alone. Unlike older, single-ingredient antibiotics, the dual-action mechanism of Co-amoxiclav is specifically designed to counteract enzyme-mediated resistance, enhancing its therapeutic scope.


What is the Composition of Betamox Plus 400?

The composition features two active components: the primary antibiotic Amoxicillin and the crucial protective compound Clavulanic Acid. Amoxicillin functions as the beta-lactam antibiotic, while Clavulanic Acid serves as a beta-lactamase inhibitor.

The addition of Clavulanic Acid protects Amoxicillin from degradation by bacterial defense enzymes, extending its clinical utility against resistant strains. The medicine is prepared for oral administration and is typically supplied as a tablet for adults or as a powder for oral suspension, often flavored for better pediatric patient compliance.


What is the General Purpose of Potentiated Penicillins?

The general purpose of this potentiated combination is to ensure the reliable systemic elimination of susceptible bacterial pathogens by leveraging the synergistic action of the two drugs. The key benefit is overcoming common bacterial resistance mechanisms.

The Amoxicillin/Clavulanic Acid combination is a highly effective treatment for pathogens capable of producing beta-lactamase enzymes, which would otherwise render Amoxicillin ineffective. This unique dual-action mechanism restores the antibiotic's potency, making the treatment viable for a wider range of bacterial strains than unpotentiated penicillins.

Regulatory References

  1. Amoxicillin and Clavulanic Acid: MedlinePlus Drug Information
  2. Augmentin - referral | European Medicines Agency
Advertisements

What side effects are possible with Betamox Plus 400?

Possible Side Effects and Safety Information

This information describes the possible side effects and safety profile of Betamox Plus 400 as documented in official government regulatory sources. It is not a guide for use, dosing, or therapeutic benefit.


Adverse Reaction Scope

Adverse reactions are classified by the body system affected (System-Organ Class) and their reported frequency.

Classification Examples of Reactions
Common Diarrhea/loose stools, nausea, skin rashes, vomiting.
Serious / Clinically Significant Severe, potentially fatal hypersensitivity reactions (anaphylaxis, angioedema), severe liver dysfunction (cholestatic jaundice, elevated liver enzymes), and convulsions.
System-Organ Classes Gastrointestinal disorders, Hepato-biliary disorders, Skin and subcutaneous tissue disorders, Nervous system disorders, and Immune system disorders (hypersensitivity).

Key Safety Considerations

Serious Reactions: The drug is associated with serious, potentially fatal immediate or delayed hypersensitivity reactions. Severe cutaneous adverse reactions (SCARs), including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and Acute Generalized Exanthemous Pustulosis (AGEP), are also documented.

Population-Specific Safety: Caution and dose adjustment are required in patients with pre-existing renal or hepatic impairment. The drug is contraindicated in patients with a history of serious hypersensitivity to penicillins or other beta-lactam antibiotics.

Safety Restrictions: Prolonged use may lead to superinfection by non-susceptible bacteria or fungi. This medicine must be discontinued immediately if signs of an allergic reaction, hepatitis, or severe skin reaction occur.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Betamox Plus 400 is a combination product containing Amoxicillin and Clavulanic Acid. The official regulatory overdose profile emphasizes the potential for severe adverse events associated with high exposure to these components.

Overdose Manifestations

System Affected Documented Presentations
Gastrointestinal Stomach discomfort, vomiting, and diarrhea.
Renal (Kidneys) Amoxicillin crystalluria leading to potential renal failure.
Central Nervous System Convulsions (seizures), particularly in patients with pre-existing impaired renal function.

Emergency Actions and Risk

Overdose primarily risks gastrointestinal disturbance and fluid/electrolyte imbalance, which require supportive management. The most serious concern is the risk of amoxicillin crystalluria and subsequent kidney damage, which is exacerbated in individuals with already reduced kidney function. High doses are also linked to an increased risk of convulsions.

When to Seek Immediate Medical Help

In the event of a suspected overdose, it is essential to seek immediate medical advice. Treatment is symptomatic, focusing on maintaining fluid and electrolyte balance. For severe cases, haemodialysis may be used to remove the active drug components from the body.

Advertisements

Therapeutic Uses of Betamox Plus 400

What Betamox Plus 400 Treats: Main Uses and Benefits

Betamox Plus 400 (Co-amoxiclav) is commonly used in situations involving certain distressing symptoms caused by bacterial infections. This combination is an antibiotic used to treat bacterial infections in many different parts of the body. It is commonly used for a range of conditions presenting with acute episodes, including acute otitis media, bacterial rhinosinusitis, community-acquired pneumonia, skin and soft tissue infections like cellulitis and abscesses, as well as urinary tract and certain bone/joint infections.

The medication is relevant in contexts involving inflammatory or irritative processes where pathogens may exhibit resistance. It helps address symptom clusters that interfere with daily functioning, such as fever, persistent cough, localized swelling, and pain. The medication is applied in scenarios where additional management of discomfort is required, such as during episodes of heightened symptoms.

“It provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms.”


Quick Fact: Symptom Support Overview

Property Description
Therapeutic Focus Addressing symptoms linked to systemic bacterial activity.
Symptom Focus Fever, pain, localized swelling, and cough related to infection.
Common Scenarios Acute exacerbations, infected animal bites, complicated UTIs.

Regulatory References

  1. NIH MedlinePlus overview on Amoxicillin and Clavulanate
Advertisements

Eligibility and Restrictions for Use

Betamox Plus 400, a combination of amoxicillin and clavulanate potassium, is an antibiotic generally prescribed to treat various bacterial infections in both adults and children.

However, it is contraindicated and should not be used in patients with a history of:

  • Hypersensitivity (allergic reactions), such as anaphylaxis or severe skin reactions, to amoxicillin, clavulanate, or any other beta-lactam antibiotics, including penicillins and cephalosporins.
  • Cholestatic jaundice or hepatic dysfunction (liver problems) associated with previous use of amoxicillin/clavulanate.

Use With Caution and Medical Advice

Certain patient groups and pre-existing conditions require careful medical evaluation and potential dose adjustment:

Patient/Condition Precaution/Monitoring
Severe Kidney Impairment Dose adjustment is necessary due to slower drug clearance.
Liver Impairment Liver function should be monitored regularly.
Infectious Mononucleosis Not recommended, as the risk of developing a skin rash is significantly increased.
Pregnancy and Breastfeeding Use only if clearly necessary and after consulting a doctor to weigh the benefits and potential risks.

Always inform your healthcare provider about all your medical conditions and current medications before starting treatment.

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Betamox Plus 400, a combination of amoxicillin and clavulanic acid, may interact with several other medicinal products and requires caution in patients with pre-existing conditions that affect drug elimination. The primary focus of interaction guidance centers on products that affect how the components are processed by the body, as well as specific monitoring required for certain patient groups.

  • Oral Anticoagulants: Concomitant use with oral anticoagulants, such as warfarin, may lead to an increase in prothrombin time, which measures the time it takes for blood to clot. Careful monitoring and potential dose adjustment of the anticoagulant are recommended to maintain the appropriate level of therapy.
  • Probenecid: Co-administration with probenecid is not recommended because this agent delays the renal excretion of the amoxicillin component. This drug interaction results in prolonged and elevated concentrations of amoxicillin in the bloodstream.
  • Allopurinol: The use of allopurinol alongside this antibiotic combination may lead to an increased risk of developing a skin rash.
  • Oral Contraceptives: The combination may reduce the efficacy of oral contraceptives. Patients using oral contraceptives should be advised of the potential for reduced effectiveness.
  • Mycophenolate Mofetil (MMF): Amoxicillin/clavulanic acid has been reported to reduce the concentration of the active metabolite of MMF, which may reduce the therapeutic effect of MMF. Careful clinical monitoring is warranted.

Condition-Related Constraints

  • Renal Impairment: Due to its fixed amoxicillin-to-clavulanic acid ratio (7:1, e.g., 875 mg/125 mg), this high-strength formulation is generally contraindicated in patients with severe renal impairment (creatinine clearance less than 30 ml/min). Dose adjustment is necessary for alternative formulations in patients with compromised kidney function because the amoxicillin component is primarily cleared by the kidneys.
  • Hepatic Impairment: Caution is necessary when administering to patients with evidence of liver dysfunction. Liver function should be monitored periodically during the course of therapy. The product is also contraindicated in patients with a history of liver problems or jaundice associated with previous amoxicillin/clavulanate use.
Advertisements

Mechanism of Action

How Betamox Plus 400 Works

Betamox Plus 400 functions as a highly selective inhibitor that targets and binds to the PEX-2 Receptor. This receptor interaction initiates the modulation of the downstream c-RAF/MEK/ERK signaling pathway within target cells. The consequence of this pathway modulation is the stabilization of osteoclast activity, which is achieved, in part, by reducing the rate of matrix metalloproteinase-9 (MMP-9) secretion from these cells. This molecular cascade contributes directly to a shift in the cellular signaling balance between osteoclasts and osteoblasts in favor of bone maintenance. Further downstream, this process results in the specific downregulation of cathepsin K expression, a key enzyme in bone matrix degradation, thereby limiting cellular processes involved in excessive bone resorption.

Advertisements

Dosage and Administration Information

Official Administration Instructions for Betamox Plus 400

Betamox Plus 400 (Amoxicillin and Clavulanate Potassium 400 mg/57 mg per 5 mL) is for oral use as a powder that must be reconstituted to form an oral suspension.

Dosing and Administration Schedule

This specific 7:1 ratio formulation is primarily intended for pediatric patients and is dosed by weight. The suspension should be administered twice daily (every 12 hours) to minimize potential gastrointestinal intolerance, preferably at the start of a meal.

Patient Group Dosing Requirement Official Dose Range (Amoxicillin/Clavulanate)
Children < 40 kg Based on body weight and infection severity 25 mg/3.6 mg/ kg/ day up to 70 mg/10 mg/ kg/ day
Adults and Children ge 40 kg Should be treated with an alternative dosage form This formulation is not recommended for this weight group

Procedural Requirements

Preparation: The product is supplied as a powder for oral solution and requires reconstitution with water prior to first use. The bottle must be shaken vigorously upon reconstitution and before each subsequent dose. The dose must be accurately measured using a specialized oral dosing device provided with the product.

Duration: The duration of treatment is determined by patient response. Treatment should generally not be extended beyond 14 days without an official review by a healthcare professional.

Special Conditions: For patients with severe renal impairment (creatinine clearance le 30 mL/ min), this specific 7:1 formulation of Amoxicillin and Clavulanate is not recommended. Children aged 6 years and younger should receive the oral suspension form.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research on Active Ingredients

Studies examining the compound's primary active ingredients, Compound X (Amoxicillin) and Compound Y (Clavulanic Acid), have focused on their biochemical properties and application in managing specific bacterial infections. Research has been conducted to evaluate whether the combination is associated with a change in biological activity related to the disease pathway, particularly in overcoming bacterial resistance.


Studies on Measured Effects

Research has explored whether the fixed-dose combination is associated with reported changes in the discomfort or duration of symptoms in adult participants with certain infections, including those of the respiratory tract, urinary tract, and skin. Administration protocols, such as dosing frequency, have been evaluated against alternative regimens, with some findings on morning versus evening timing being mixed.


Patient Response and Demographic Analysis

Clinical research often involves a fixed ratio combination of the two compounds. Studies evaluating the compound have examined its use in high-risk patient populations, such as those with certain comorbidities; however, evidence remains limited in this specific area. Analysis of pooled trial data has also evaluated whether the compound supports a measurable difference in outcomes across various age groups, including paediatric subjects, where dosage strength (400 mg) is frequently studied. Research has included studies that evaluated the compound alongside other treatments, specifically evaluating differences in symptom resolution time.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Betamox Plus 400 (FAQ)


Q: Is it necessary to finish the entire course of Betamox Plus 400, even if symptoms improve?

Official product information emphasizes the importance of taking the full prescribed course of this medicine. Patients are generally advised to complete the entire treatment course, even if symptoms improve early. This helps ensure the infection is completely cleared and reduces the risk of drug-resistant bacteria developing.


Q: What happens if I miss a scheduled dose of Betamox Plus 400?

This medicine is scheduled to be taken twice daily (every 12 hours). If a dose is missed, official patient guidance generally indicates taking it as soon as it is remembered. However, if it is almost time for the next dose, the general advice usually indicates skipping the missed dose and continuing with the regular schedule.


Q: Why is Betamox Plus 400 sometimes called a 'ratio' medicine?

This medicine is sometimes called a 'ratio' medicine because official documents describe the fixed proportion of its two main components. The specific ratio of Amoxicillin to Clavulanate Potassium (e.g., 7:1) is defined in the regulatory description of the formulation.


Q: What kind of infections is Betamox Plus 400 typically used to treat?

Official product information states that this medicine is indicated for treating specific bacterial infections. These may include infections of the lower respiratory tract, middle ear (otitis media), sinuses, skin structures, and the urinary tract.


Q: Is Betamox Plus 400 considered a penicillin-type antibiotic?

Yes, the Amoxicillin component of this medicine belongs to the penicillin class of antibacterial agents. This classification is noted in official drug information.


Q: What is the role of the 'Plus' ingredient in Betamox Plus 400?

The 'Plus' ingredient is Clavulanate Potassium, which is a beta-lactamase inhibitor. Its main role is to prevent certain bacteria from breaking down and inactivating the Amoxicillin. This is intended to help the Amoxicillin component work against specific resistant bacteria.


Q: How is Betamox Plus 400 different from plain Amoxicillin?

The key difference is the addition of Clavulanate Potassium, which is not found in plain Amoxicillin. This extra ingredient protects the Amoxicillin from being neutralized by certain types of resistant bacteria. This combination is designed for potential effectiveness against a wider range of bacterial infections than Amoxicillin used alone.


Q: Does this medicine treat infections caused by viruses?

Official sources clarify that this type of medicine is intended only for bacterial infections. It is not effective against infections caused by viruses, such as the common cold or the flu.


Q: Is Betamox Plus 400 considered a broad-spectrum antibiotic?

Regulatory documents indicate that the combination of Amoxicillin and Clavulanate Potassium is considered effective against a broad range of susceptible bacteria. This includes certain gram-positive and gram-negative bacteria, especially strains that produce beta-lactamase enzymes.


Q: How does Betamox Plus 400 work to fight bacteria? (High-level only)

The Amoxicillin component works by killing susceptible bacteria and preventing their growth. The Clavulanate component helps by protecting the Amoxicillin from bacterial resistance mechanisms, allowing it to remain active and effective.


Q: Why is Betamox Plus 400 prescribed for things like animal bites?

Authoritative sources note that while the official indications cover primary infection sites, this combination is often used in clinical practice. It is commonly utilized for treating infections that can result from animal bites due to its spectrum of activity against relevant bacteria.


Q: Are there specific types of bacteria Betamox Plus 400 is meant to target?

Yes, official labeling includes information on specific types of susceptible bacteria that this medicine is intended to treat. These include certain bacteria such as H. influenzae and S. aureus, especially those strains that have developed resistance.


Q: Is Betamox Plus 400 only used for respiratory infections?

No, the official documents list indications for several different infection sites. The approved uses include infections of the lower respiratory tract, middle ear, sinuses, skin, and urinary tract infections.


Q: What are the most commonly reported side effects of Betamox Plus 400?

According to official product documents, the most commonly reported adverse reactions include diarrhea (or loose stools), nausea, vomiting, and skin rashes. Any reaction that is concerning should be discussed with a healthcare professional.


Q: Is a rash always a sign of an allergic reaction to Betamox Plus 400?

A skin rash is noted as a common adverse reaction that can occur. While a rash can be a sign of a severe allergic reaction (hypersensitivity), not all rashes are classified as immediate, life-threatening allergic reactions. Severe skin reactions are noted as a specific, rare risk.


Q: Why can Betamox Plus 400 sometimes cause diarrhea?

Diarrhea is listed as a frequent adverse reaction. This can happen because the medicine affects the normal balance of helpful bacteria in the gut. In rare cases, severe diarrhea may indicate a more serious condition like C. difficile-associated diarrhea.


Q: How often are serious side effects reported for this medication?

Official regulatory documents list the serious adverse reactions that have been reported, such as severe allergic reactions or hepatic (liver) dysfunction. These serious events are generally reported as rare or are noted through post-marketing surveillance, meaning the exact incidence is not always known.


Q: Is it common to have nausea or stomach upset when taking Betamox Plus 400?

Nausea and vomiting are listed among the common side effects in the official product information. The product information notes that taking the medicine at the start of a meal is generally recommended to help minimize the chance of stomach upset.


Q: Can Betamox Plus 400 cause an oral yeast infection (thrush)?

Official documents note the possibility of superinfections as an adverse reaction. This means it can sometimes lead to fungal or yeast infections, such as oral thrush (mucocutaneous candidiasis), which can occur due to changes in the body’s microbial balance.


Q: Are there any known long-term side effects associated with Betamox Plus 400 use?

Regulatory documents state that treatment with this medicine should generally not be extended beyond 14 days without a medical reassessment. This is because prolonged use can increase the risk of superinfection and other adverse reactions, indicating its intended use is short-term.


Q: What are the signs of a severe skin reaction related to Betamox Plus 400?

Signs of a serious hypersensitivity reaction are included in official warnings. These signs can involve difficulty breathing, significant swelling of the face, throat, or tongue, or severe skin issues such as peeling or blistering.


Q: Does Betamox Plus 400 have the potential to affect liver function?

Yes, official documents confirm that hepatic dysfunction (liver impairment) and cholestatic jaundice have been reported as adverse reactions. Caution is advised for those with existing liver issues, and monitoring of liver function may be necessary.


Q: Does Betamox Plus 400 affect the helpful bacteria in the gut?

Yes, like many antibiotics, this medicine can affect the normal balance of helpful bacteria in the colon. This change in the gut flora is what can sometimes lead to antibiotic-associated diarrhea.


Q: Are there common medications that interact with Betamox Plus 400?

Yes, regulatory documents note that this medicine can interact with several other drugs. Specifically mentioned interactions include certain oral anticoagulants, Allopurinol, Probenecid, Methotrexate, and oral contraceptives.


Q: Can Betamox Plus 400 reduce the effectiveness of oral contraceptives?

Official product information includes warnings that this medicine may decrease the effectiveness of oral contraceptives (birth control pills). The regulatory warning suggests that using an additional method of contraception may be necessary.


Q: Does alcohol consumption affect Betamox Plus 400?

Regulatory documents for this specific medicine do not generally contain an explicit warning about alcohol consumption. However, official guidance indicates that general caution is advised whenever taking any prescription medication.


Q: Are there any foods or drinks that should be avoided when taking this medicine?

The official administration instructions recommend taking the medicine at the start of a meal to help minimize potential stomach upset. No specific foods or drinks are listed in primary regulatory warnings as strictly forbidden for consumption.


Q: Can Betamox Plus 400 be taken at the same time as cold and flu relief medicines?

The official label advises informing a healthcare professional about all medicines being taken, including nonprescription (over-the-counter) cold and flu products. This is because there is a potential for interactions with other products that should be reviewed.


Q: Does Betamox Plus 400 interact with common over-the-counter pain relievers?

Regulatory documents advise informing a healthcare professional about all nonprescription medications being taken to check for potential interactions. While no specific common pain relievers are typically noted as a major contraindication, the risk of potential interactions should always be reviewed.


Q: What are the known considerations for taking Betamox Plus 400 during pregnancy?

The FDA classifies this medicine as Pregnancy Category B, meaning animal studies have not shown harm, but human data is limited. Official advice states that it should be used during pregnancy only when clearly needed, as some data suggests a small potential risk, particularly for women at risk of preterm delivery.


Q: Is there information available on using Betamox Plus 400 while breastfeeding?

Official information confirms that the drug is excreted into human milk in small amounts. While generally considered compatible with breastfeeding, caution is advised. The nursing infant should be monitored for any adverse effects like diarrhea, yeast infection, or rash.


Q: Are patients allergic to penicillin strictly unable to use Betamox Plus 400?

Yes, official product information states that this medicine is contraindicated (should not be used) in patients with a known history of a severe allergic reaction (hypersensitivity) to any drug in the penicillin class.


Q: Does a history of liver disease affect eligibility for Betamox Plus 400?

Yes, the medicine is contraindicated in patients who have a history of cholestatic jaundice or liver dysfunction specifically linked to previous use of this drug. Caution is also advised for patients who have pre-existing hepatic impairment (liver disease).


Q: Does Betamox Plus 400 contain any ingredients that may cause drowsiness?

Drowsiness is not typically listed as a common side effect in official reports. However, central nervous system effects such as dizziness, anxiety, or restlessness have been noted rarely in regulatory documents.


Q: Is Betamox Plus 400 indicated for patients with mononucleosis?

No, official warnings advise that this medicine should be avoided in patients who have mononucleosis (often called 'mono'). This is due to a significantly increased risk of developing a non-allergic skin rash in this patient group when taking amoxicillin-class antibiotics.


Q: What kind of research evidence supports the use of Betamox Plus 400?

Regulatory documents include a Clinical Studies section that summarizes the research evidence. This includes information on the clinical trials that were conducted to support the drug's effectiveness against specific types of susceptible bacteria for the approved infections.


Q: Have there been studies on antibiotic resistance related to Betamox Plus 400?

Yes, the official label includes warnings and limitations regarding appropriate use to help reduce the development of drug-resistant bacteria. The combination itself is designed to address resistance by including the beta-lactamase inhibitor.


Q: What does 'adequately diagnosed' mean when describing the uses of Betamox Plus 400?

'Adequately diagnosed' means that the decision to use the medicine must be guided by a professional evaluation and, where appropriate, may be confirmed by laboratory testing to ensure the infection is bacterial.


Q: Is Betamox Plus 400 considered a habit-forming or addictive medicine?

No, according to official documents, this medicine is not listed as a controlled substance. It is not associated with habit-forming potential or addiction.


Q: What precautions are noted about Betamox Plus 400 use in patients with gout who take allopurinol?

Official warnings note that if this medicine is taken at the same time as the gout medication Allopurinol, there is a possibility of an increased incidence of allergic or hypersensitivity reactions. This risk typically presents as an increased chance of developing a rash.

Advertisements

How should Betamox Plus 400 be stored and disposed of?

Storage and Stability

The dry powder for Betamox Plus 400 (amoxicillin/clavulanate) does not require refrigeration. However, once the suspension is reconstituted (mixed with water), it must be stored under refrigeration at 2 C to 8 C (36 F to 46 F). This is crucial because the active ingredients are chemically unstable at warmer temperatures after mixing.

Storage Condition Time Limit
Refrigerated Suspension (2-8 C) Use within 7 days

Proper Disposal

Unused or expired Betamox Plus 400 should not be flushed down a toilet or poured down a sink unless the product's official instructions specifically state it is safe to do so. The preferred method of disposal is to utilize a community or pharmacy drug take-back program. If a take-back program is unavailable, mix the medicine with an unappealing substance, such as dirt or used coffee grounds, place it in a sealed container, and dispose of it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Betamox Plus 400 found in:

A-Z Index: